Advertisement

Topics

Latest "Schreiner Group GmbH & Co.KG" News Stories

13:29 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Schreiner Group GmbH & Co.KG" found in our extensive news archives from over 250 global news sources.

More Information about Schreiner Group GmbH & Co.KG on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Schreiner Group GmbH & Co.KG for you to read. Along with our medical data and news we also list Schreiner Group GmbH & Co.KG Clinical Trials, which are updated daily. BioPortfolio also has a large database of Schreiner Group GmbH & Co.KG Companies for you to search.

Showing "Schreiner Group GmbH" News Articles 1–25 of 7,700+

Monday 18th March 2019

Advanced Bionics Starts 2019 Strong with Innovations Benefiting Consumers and Professionals

—The leader in cochlear implants releases exciting product upgrades to meet the needs of the marketplace— Advanced Bionics (AB) demonstrates its commitment to their customers and hearing professionals by announcing a wide range of product enhancements to their innovative hearing solutions. Among these are the


CURE Media Group Named the 2019 Ovarian Cancer Heroes®

CURE Media Group’s flagship product, CURE® magazine, which reaches over a million patients, survivors and caregivers and is dedicated to providing cancer updates, announced the 2019 Ovarian Cancer Heroes® who have made a difference in the field. The event was held during the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer. This...

Scientists call for moratorium on editing heritable genes

A group of scientists and ethicists, writing in Nature, have called for a global moratorium on all clinical uses of human germline editing to make genetically modified children.1Among those calling...


DxPx: The First International Diagnostics Partnering Conference

15 start-ups to present their business – founders apply now Organizer SilverSky LifeSciences wins Roche Diagnostics, Bioscientia, and Research Analytica as first renowned partners Diagnostics is one of the fastest growing medical disciplines. Therefore it has been only a matter of time for a fair to focus exclusively on this important topic:...

HAEMATO AG: Preliminary Results 2018

DGAP-News: HAEMATO AG / Key word(s): Preliminary Results 18.03.2019 / 15:14 The issuer is solely responsible for the content of this announcement. Corporate News of HAEMATO AG: HAEMATO AG was able to achieve an EBITDA of EUR 10.0m for the fiscal year 2018 according to preliminary IFRS financial statements. HAEMATO AG, Berlin (ISIN: DE0006190705), achieved consolidated sales of EUR 27...

Attica Bank (TATT) - Balance sheet repair nears completion

Edison Investment Research - Financials - Attica Bank: Through the Artemis and Metexelixis securitisations, Attica’s exposure to impaired loans has reduced significantly and now compares favourably with the larger Greek banks. Management forecasts common equity Tier 1 to increase from 12.2% to 13.2% at year end, representing significant headroom over regulatory requirements. Management will ...

Swenson Healthcare Adds Two Executives

Washington post-acute practice group responds to rising demand for its services Swenson Healthcare, a clinical practice group dedicated to the care of patients in post-acute care facilities, announced today the addition of two senior managers to newly created positions on the executive team, effective immediately. This press release features mult...

Diagnostics Data Analytics Company Diaceutics to List on London Stock Exchange

Company seeking £53M IPO on London Stock Exchange junior market, AIM (Alternative Investment Market) Diaceutics expects the addressable market for its specific services to grow to US$2.5BN by 2023 Diaceutics plc, a revenue-generating and profitable diagnostics data analytics and implementation services company which ...

Sterna Biologicals holds Scientific Advisory Board meeting at 14th Congress of ECCO to advance phase IIb clinical development program of SB012 in Ulcerative Colitis

DGAP-News: sterna biologicals GmbH & Co. KG / Key word(s): Miscellaneous 18.03.2019 / 14:00 The issuer is solely responsible for the content of this announcement. STERNA BIOLOGICALS HOLDS SCIENTIFIC ADVISORY BOARD MEETING AT 14th CONGRESS OF ECCO TO ADVANCE PHASE IIb CLINICAL DEVELOPMENT PROGRAM OF SB012 IN ULCERATIVE COLITIS Meeting included international key opinion leaders Inpu...

STAT Plus: Pharmalittle: Gilead boosts prices by nearly 5 percent; a ‘patient access’ group is really funded by pharma

The Alliance for Patient Access, a nonprofit group that gives off a consumer-friendly vibe, is bankrolled by the pharmaceutical industry.

Edison initiates coverage on Actinogen Medical (ACW)

Edison Investment Research Limited 18-March-2019 / 12:33 GMT/BST London, UK, 18 March 2019 Edison initiates coverage on Actinogen Medical (ACW) Actinogen Medical is an ASX-listed Australian biotech developing its lead asset Xanamem to treat cognitive impairment that occurs in chronic neurodegenerative diseases. Xanamem(R) is a selective 11β-HSD1 inhibitor that is able to cross the bloo...

miR Scientific Presents a New Non-invasive Test for Identifying Clinically Significant Prostate Cancer

New Highly-Sensitive Detection Technology using miRNA and snoRNA Expression Signatures Unveiled at EAU 2019 Proprietary, non-invasive liquid biopsy urine test definitively detects, accurately scores and continuously monitors prostate and bladder cancers miR Scienti

Change Healthcare Releases the 9th Annual Industry Pulse Survey

U.S. healthcare leaders share insights on trends and issues facing payers, providers, and the businesses that serve the market. Top findings: Significant forces are causing payers and providers to rethink business models; a greater focus on social determinants of health; continued challenges with risk sharing Today Change Healthcare and the

vTv Therapeutics Announces $15 Million of Class A Common Stock Financings

Proceeds Will Fund Start-Up Activities for Current and Future Clinical Trials vTv Therapeutics Inc. (Nasdaq:VTVT) (the “Company”) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered direct offering (the “Registered Direct Offering”) of 3,636,364 shares of...

3M Announces New Business Segments and Leadership Appointments

New Structure Increases Customer Focus, Agility and Productivity 3M today announced the realignment of the company from five to four business segments. The new alignment will enable the company to better serve global customers and markets. “We are continuing to advance 3M into the future, and today’s actions will strengthen our ability to ...

Minerva Neurosciences, Inc: Minerva Neurosciences to Host Webcast Event on Schizophrenia

Decision Resources Group to provide review of the disease landscape and forecast Key opinion leader to discuss negative symptoms in schizophrenia Minerva to outline roluperidone's potential positio...

Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective view

Hardman & Co Research 18-March-2019 / 11:30 GMT/BST Hardman & Co Research: Take an objective view AGY is a long-established specialist in the prevention, diagnosis and treatment of allergies. The Pollinex Quattro (PQ) platform, an ultra-short-course subcutaneous allergy immunotherapy (AIT), continues to gain market share despite its availability in the EU on a 'named-patient' basis o...

Consumer Use Of Popular But Deadly Paint Stripper Banned By EPA–But Advocates Say Agency Should Have Gone Further

The EPA will still allow commercial use of the lethal chemical. The Trump administration “will be partly to blame when the next worker is injured or dies as a result of being exposed to this extremely dangerous chemical,” attorney Melanie Benesh of the Environmental Working Group said.

CSPC Pharmaceutical Announces 2018 Annual Results

Profit Attributable To Shareholders Increased 31.9% to HK$3,655 Million Innovative Drug Business Continued to Deliver Strong Growth R&D Deployment Further Improved HONG KONG, March 18, 2019 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group"), a leading pharmaceutical company...

Horizon Pharma plc Wins PR News CSR Award for Partnership with Perspectives Math and Science Academy

Horizon Pharma plc (Nasdaq: HZNP) announced today that it has won a PR News CSR Award in the Corporation category for its impactful partnership with Chicago-based charter school, Perspectives Math and Science Academy (MSA). A video highlighting the partnership can be found here. PR News’ CSR Awards celebrate organizations committed to mak

Ex-UNILAD team to lead the new WideCells business Iconic Labs Plc

Executive chairman David Sefton and the newly appointed CEO of Iconic Labs Plc John Quinlan talk Proactive London's Andrew Scott through the restructure of the existing WideCells Group PLC (LON:WDC) and the focus of its new media business. The group, which previously focused on stem cell research, will now be targeting online marketing, content, and technology products designed to create brand...

WideCells shares rocket as it plans to become Iconic Labs and brings in former UNILAD execs to head new media business

The group, which previously focused on stem cell research, said John Quinlan and Liam Harrington would be joining the board immediately as chief executive and chief business officer respectively

Ohio accuses UnitedHealth's OptumRx of drug overcharges in lawsuit

Ohio's attorney general on Monday said he had filed a lawsuit against UnitedHealth Group Inc's OptumRx unit, saying the pharmacy benefit manager had overcharged the state nearly $16 million for prescription drugs.

Fresenius Medical Care AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Fresenius Medical Care AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements 18.03.2019 / 10:28 Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------...

Cronos Group: The Bulls Remain In Control For Now


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks